• Conference Proceeding

Budget Impact of Adding Delayed-Release Dimethyl Fumarate to the Formulary for the Treatment of Relapsing Forms of Multiple Sclerosis

Citation

Mauskopf, J. A., Fay, M., Iyer, R., & Livingston, T. (2014). Budget Impact of Adding Delayed-Release Dimethyl Fumarate to the Formulary for the Treatment of Relapsing Forms of Multiple Sclerosis. In [17], pp. A58–A58. .

Abstract